XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.23.1

SHAREHOLDERS' EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2022
Stockholders' Equity Note [Abstract] |
SHAREHOLDERS' EQUITY |
NOTE 12: - | SHAREHOLDERS' EQUITY
| a. | Company's shares:
As of December 31, 2022, the Company's authorized share capital consists of NIS 20,000,000 divided into 200,000,000 Ordinary Shares, par value NIS 0.1 per share. Ordinary Shares confer on their holders the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company, and the right to receive dividends if declared.
| b. | Share option plan:
A summary of the Company's share option activity, pertaining to its option plans for employees and related information is as follows:
|  | Year ended December 31, |
|  | 2022 |  |  | 2021 |  |  | 2020 |
|  | Number of shares upon exercise |  |  | Weighted average exercise price |  |  | Number of shares upon exercise |  |  | Weighted average exercise price |  |  | Number of shares upon exercise |  |  | Weighted average exercise price |
Outstanding at beginning of year |  |  | 675,986 |  |  | $ | 7.99 |  |  |  | 1,134,256 |  |  | $ | 7.68 |  |  |  | 1,453,741 |  |  | $ | 7.59 |
Granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited |  |  | (139,494 | ) |  | $ | 16.08 |  |  |  | (30,861 | ) |  | $ | 16.78 |  |  |  | (28,657 | ) |  | $ | 17.47 |
Exercised |  |  | (48,653 | ) |  | $ | 5.01 |  |  |  | (427,409 | ) |  | $ | 6.54 |  |  |  | (290,828 | ) |  | $ | 6.25 |
Outstanding at end of year |  |  | 487,839 |  |  | $ | 5.96 |  |  |  | 675,986 |  |  | $ | 7.99 |  |  |  | 1,134,256 |  |  | $ | 7.68 |
Exercisable at end of year |  |  | 487,839 |  |  | $ | 5.96 |  |  |  | 660,986 |  |  | $ | 8.04 |  |  |  | 1,065,498 |  |  | $ | 7.83 |
Vested and expected to vest |  |  | 487,839 |  |  | $ | 5.96 |  |  |  | 675,584 |  |  | $ | 7.99 |  |  |  | 1,132,007 |  |  | $ | 7.68 |
The aggregate intrinsic value represents the total intrinsic value (the difference between the Company's closing share price on the last trading day of the fiscal years 2022, 2021 and 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders exercised their options on December 31, 2022, 2021 and 2020, respectively. This amount may change based on the fair market value of the Company's share. The total intrinsic value of options outstanding as of December 31, 2022, 2021 and 2020, were $10, $3,481and $4,578, respectively. The total intrinsic value of exercisable options as of December 31, 2022, 2021 and 2020, were approximately $10, $3,392 and $4,226, respectively. The total intrinsic value of options vested and expected to vest as of December 31, 2022, 2021 and 2020, were approximately $10, $3,479 and $4,568, respectively. The total intrinsic value (the difference between the Company's closing share price on the exercise date and the exercise price) of options exercised during the years ended December 31, 2022, 2021 and 2020 were approximately $93, $4,113 and $1,437, respectively. The number of options vested during the year ended December 31, 2022 was 15,000. The weighted-average remaining contractual life of the outstanding options as of December 31, 2022 is 1.34 years. The weighted-average remaining contractual life of exercisable options as of December 31, 2022 is 1.34 years. The options outstanding as of December 31, 2022, have been classified by exercise price, as follows:
Exercise price |  |  | Shares upon exercise of options outstanding as of December 31, 2022 |  |  | Weighted average remaining contractual life |  |  | Shares upon exercise of options exercisable as of December 31, 2022 |
|  |  |  |  |  | Years |  |  |  |
$ | 15.2-17.07 |  |  |  | 4,500 |  |  |  | 1.12 |  |  |  | 4,500 |
$ | 10.0 -14.68 |  |  |  | 52,750 |  |  |  | 0.78 |  |  |  | 52,750 |
$ | 5.01-9.7 |  |  |  | 73,563 |  |  |  | 2.28 |  |  |  | 73,563 |
$ | 0.1-4.95 |  |  |  | 357,026 |  |  |  | 1.23 |  |  |  | 357,026 |
|  |  |  |  | 487,839 |  |  |  |  |  |  |  | 487,839 |
The following provides a summary of the restricted share unit activity for the Company for the two years ended December 31, 2022:
|  | Year ended December 31, |
|  | 2022 |  |  | 2021 |
|  | Number of shares upon exercise |  |  | Weighted average share price |  |  | Number of shares upon exercise |  |  | Weighted average share price |
Outstanding at beginning of year |  |  | 1,937,908 |  |  | $ | 12.92 |  |  |  | 1,763,017 |  |  | $ | 8.63 |
Granted |  |  | 1,473,400 |  |  | $ | 5.22 |  |  |  | 1,149,500 |  |  | $ | 16.26 |
Vested |  |  | (829,910 | ) |  | $ | 15.82 |  |  |  | (681,433 | ) |  | $ | 15.82 |
Forfeited |  |  | (325,778 | ) |  | $ | 5.78 |  |  |  | (293,176 | ) |  | $ | 16.39 |
Unvested at end of year |  |  | 2,255,620 |  |  | $ | 8.52 |  |  |  | 1,937,908 |  |  | $ | 12.92 |
As of December 31, 2022, $12,648,859 unrecognized compensation cost related to RSUs is expected to be recognized over a weighted average vesting period of 1.96 years. Under the terms of the above option plans, options may be granted to employees, officers, directors and various service providers of the Company and its subsidiaries. The options vest over a four-year period, subject to the continued employment of the employee. The options generally expire no later than ten years from the date of the grant. The exercise price of the options at the date of grant under the plans may not be less than the nominal value of the shares into which such options are exercised, any options, which are forfeited or cancelled before expiration, become available for future grants. As of December 31, 2022, 193,679 Ordinary shares are available for future issuance under the option plans. The Company granted 1,473,400 and 1,149,500 RSUs in 2022 and 2021, respectively under the 2016 option plan. RSUs vest over a period of between three to four years, subject to the continued employment of the employee. RSUs that are cancelled or forfeited become available for future grants.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration